Matti Virkki

Title: Matti Virkki: Innovator in Pharmaceutical Composition

Introduction

Matti Virkki is a notable inventor based in Masala, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. With a total of 2 patents, his work has garnered attention for its innovative approach to medication formulation.

Latest Patents

Matti Virkki's latest patents include a pharmaceutical composition comprising entacapone, levodopa, and carbidopa. This oral solid fixed dose composition contains pharmacologically effective amounts of these compounds, or their pharmaceutically acceptable salts or hydrates, along with at least one pharmaceutically acceptable excipient. The composition is designed for the treatment of Parkinson's disease, showcasing its potential to improve patient outcomes.

Career Highlights

Matti Virkki is associated with Orion Corporation, a leading company in the pharmaceutical industry. His work at Orion has allowed him to focus on developing effective treatments for neurological conditions, contributing to the advancement of medical science.

Collaborations

Throughout his career, Matti has collaborated with talented professionals such as Kari Vahervuo and Marja Ritala. These partnerships have enhanced his research and development efforts, leading to innovative solutions in the pharmaceutical sector.

Conclusion

Matti Virkki's contributions to pharmaceutical innovation, particularly in the treatment of Parkinson's disease, highlight his role as a significant inventor in the field. His patents reflect a commitment to improving healthcare through effective medication formulations.